ASX - By Stock
|
PER |
Re:
Ann: Receipt of R&D Tax Incentive payment
|
|
Baremoney
|
65 |
18K |
1 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
65
|
18K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Introduction to the Duchenne Community
|
|
Baremoney
|
17 |
3.9K |
9 |
28/11/20 |
28/11/20 |
ASX - By Stock
|
17
|
3.9K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Introduction to the Duchenne Community
|
|
Baremoney
|
17 |
3.9K |
21 |
28/11/20 |
28/11/20 |
ASX - By Stock
|
17
|
3.9K
|
21
|
|
ASX - By Stock
|
PER |
Re:
Introduction to the Duchenne Community
|
|
Baremoney
|
17 |
3.9K |
3 |
27/11/20 |
27/11/20 |
ASX - By Stock
|
17
|
3.9K
|
3
|
|
ASX - By Stock
|
PER |
Re:
One Study Away
|
|
Baremoney
|
35 |
9.0K |
0 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
35
|
9.0K
|
0
|
|
ASX - By Stock
|
PER |
Re:
One Study Away
|
|
Baremoney
|
35 |
9.0K |
1 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
35
|
9.0K
|
1
|
|
ASX - By Stock
|
PER |
Re:
One Study Away
|
|
Baremoney
|
35 |
9.0K |
1 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
35
|
9.0K
|
1
|
|
ASX - By Stock
|
PER |
Re:
One Study Away
|
|
Baremoney
|
35 |
9.0K |
5 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
35
|
9.0K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Investor Presentation
|
|
Baremoney
|
26 |
5.8K |
0 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
26
|
5.8K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Investor Presentation
|
|
Baremoney
|
26 |
5.8K |
5 |
18/11/20 |
18/11/20 |
ASX - By Stock
|
26
|
5.8K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP raises A$7.3 million from Oversubscribed Placement
|
|
Baremoney
|
54 |
13K |
21 |
12/11/20 |
12/11/20 |
ASX - By Stock
|
54
|
13K
|
21
|
|
ASX - By Stock
|
PER |
Re:
AGM
|
|
Baremoney
|
70 |
14K |
0 |
12/11/20 |
12/11/20 |
ASX - By Stock
|
70
|
14K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP raises A$7.3 million from Oversubscribed Placement
|
|
Baremoney
|
54 |
13K |
15 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
54
|
13K
|
15
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Baremoney
|
23 |
6.1K |
16 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
23
|
6.1K
|
16
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Baremoney
|
23 |
6.1K |
2 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
23
|
6.1K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Baremoney
|
23 |
6.1K |
2 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
23
|
6.1K
|
2
|
|
ASX - By Stock
|
PER |
Re:
AGM
|
|
Baremoney
|
70 |
14K |
3 |
04/11/20 |
04/11/20 |
ASX - By Stock
|
70
|
14K
|
3
|
|
ASX - By Stock
|
PER |
Re:
EMA ODD
|
|
Baremoney
|
2 |
953 |
12 |
03/11/20 |
03/11/20 |
ASX - By Stock
|
2
|
953
|
12
|
|
ASX - By Stock
|
PER |
Re:
Taylor iniitates coverage of ANP with SP target of $0.27 undiluted
|
|
Baremoney
|
31 |
8.6K |
3 |
02/11/20 |
02/11/20 |
ASX - By Stock
|
31
|
8.6K
|
3
|
|
ASX - By Stock
|
PER |
Re:
DMD results
|
|
Baremoney
|
25 |
6.2K |
0 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
25
|
6.2K
|
0
|
|
ASX - By Stock
|
PER |
Re:
DMD results
|
|
Baremoney
|
25 |
6.2K |
18 |
28/10/20 |
28/10/20 |
ASX - By Stock
|
25
|
6.2K
|
18
|
|
ASX - By Stock
|
PER |
Re:
Ann: Pause in Trading
|
|
Baremoney
|
97 |
24K |
2 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
97
|
24K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Baremoney
|
1 |
1.1K |
0 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
1
|
1.1K
|
0
|
|
ASX - By Stock
|
PER |
Re:
ODD....DESIGNATED!! here we go!
|
|
Baremoney
|
25 |
7.2K |
5 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
25
|
7.2K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Ceasing to be a substantial holder from AEF
|
|
Baremoney
|
44 |
9.1K |
4 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
44
|
9.1K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Update and Appendix 4C
|
|
Baremoney
|
8 |
2.4K |
1 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
8
|
2.4K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Ceasing to be a substantial holder from AEF
|
|
Baremoney
|
44 |
9.1K |
18 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
44
|
9.1K
|
18
|
|
Charts
|
PER |
Re:
Chart
|
|
Baremoney
|
5.9K |
2.3M |
1 |
19/10/20 |
19/10/20 |
Charts
|
5.9K
|
2.3M
|
1
|
|
Charts
|
PER |
Re:
Chart
|
|
Baremoney
|
5.9K |
2.3M |
0 |
19/10/20 |
19/10/20 |
Charts
|
5.9K
|
2.3M
|
0
|
|
ASX - By Stock
|
PER Biotech |
Re:
Research report
|
|
Baremoney
|
52 |
13K |
1 |
18/10/20 |
18/10/20 |
ASX - By Stock
|
52
|
13K
|
1
|
|
ASX - By Stock
|
PER Biotech |
Re:
Research report
|
|
Baremoney
|
52 |
13K |
0 |
18/10/20 |
18/10/20 |
ASX - By Stock
|
52
|
13K
|
0
|
|
ASX - By Stock
|
PER Biotech |
Re:
Research report
|
|
Baremoney
|
52 |
13K |
2 |
18/10/20 |
18/10/20 |
ASX - By Stock
|
52
|
13K
|
2
|
|
ASX - By Stock
|
PER Biotech |
Research report
|
|
Baremoney
|
52 |
13K |
22 |
18/10/20 |
18/10/20 |
ASX - By Stock
|
52
|
13K
|
22
|
|
ASX - By Stock
|
PER |
Re:
Go it alone or do a deal??
|
|
Baremoney
|
44 |
13K |
11 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
44
|
13K
|
11
|
|
ASX - By Stock
|
PER |
Re:
Go it alone or do a deal??
|
|
Baremoney
|
44 |
13K |
1 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
44
|
13K
|
1
|
|
ASX - By Stock
|
PER |
Re:
The Time for DMD Gene Therapy is Now: A Chat with the MDA | BioSpace
|
|
Baremoney
|
6 |
2.6K |
1 |
11/10/20 |
11/10/20 |
ASX - By Stock
|
6
|
2.6K
|
1
|
|
ASX - By Stock
|
PER |
Re:
The Time for DMD Gene Therapy is Now: A Chat with the MDA | BioSpace
|
|
Baremoney
|
6 |
2.6K |
0 |
11/10/20 |
11/10/20 |
ASX - By Stock
|
6
|
2.6K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Go it alone or do a deal??
|
|
Baremoney
|
44 |
13K |
7 |
11/10/20 |
11/10/20 |
ASX - By Stock
|
44
|
13K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Go it alone or do a deal??
|
|
Baremoney
|
44 |
13K |
5 |
10/10/20 |
10/10/20 |
ASX - By Stock
|
44
|
13K
|
5
|
|
ASX - By Stock
|
PER |
Re:
The Rome Cohort
|
|
Baremoney
|
80 |
19K |
0 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
80
|
19K
|
0
|
|
ASX - By Stock
|
PER |
Re:
An FDA Act that may be relvant to ATL-1102 FDA
|
|
Baremoney
|
210 |
61K |
7 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
210
|
61K
|
7
|
|
ASX - By Stock
|
PER |
Re:
An FDA Act that may be relvant to ATL-1102 FDA
|
|
Baremoney
|
210 |
61K |
3 |
04/10/20 |
04/10/20 |
ASX - By Stock
|
210
|
61K
|
3
|
|
ASX - By Stock
|
PER |
Re:
An FDA Act that may be relvant to ATL-1102 FDA
|
|
Baremoney
|
210 |
61K |
9 |
04/10/20 |
04/10/20 |
ASX - By Stock
|
210
|
61K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense to present new data at WMS Virtual Congress 2020
|
|
Baremoney
|
125 |
32K |
11 |
03/10/20 |
03/10/20 |
ASX - By Stock
|
125
|
32K
|
11
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense to present new data at WMS Virtual Congress 2020
|
|
Baremoney
|
125 |
32K |
6 |
29/09/20 |
29/09/20 |
ASX - By Stock
|
125
|
32K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Baremoney
|
71 |
23K |
3 |
28/09/20 |
28/09/20 |
ASX - By Stock
|
71
|
23K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Some parallels
|
|
Baremoney
|
15 |
5.8K |
2 |
19/09/20 |
19/09/20 |
ASX - By Stock
|
15
|
5.8K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Some parallels
|
|
Baremoney
|
15 |
5.8K |
6 |
19/09/20 |
19/09/20 |
ASX - By Stock
|
15
|
5.8K
|
6
|
|
ASX - By Stock
|
SDL |
Re:
Ann: Appendix 3G
|
|
Baremoney
|
22 |
10K |
1 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
22
|
10K
|
1
|
|
Charts
|
PER |
Re:
Chart
|
|
Baremoney
|
5.9K |
2.3M |
4 |
18/09/20 |
18/09/20 |
Charts
|
5.9K
|
2.3M
|
4
|
|